Silence Therapeutics (SLN)
NASDAQ:SLN
Holding SLN?
Track your performance easily

Silence Therapeutics (SLN) Cash flow

107 Followers

Silence Therapeutics Cash Flow

SLN's free cash flow for Q4 2022 was £-13.71M. For the 2022 fiscal year, SLN's free cash flow was decreased by £6.50M and operating cash flow was £-13.41M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
£ -45.46M£ -39.35M£ -45.46M£ 6.81M£ -10.78M£ 1.73M
Investing Cash Flow
£ -16.54M£ -19.75M£ -16.54M£ 8.68M£ 9.62M£ -15.02M
Financing Cash Flow
£ 43.05M£ 61.34M£ 43.05M£ 30.71M£ 15.43M£ 5.27M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
£ 255.69M£ 54.03M£ 54.82M£ 73.54M£ 27.45M£ 13.52M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
£ 43.24M£ 25.33M£ 43.24M£ 30.92M£ 15.83M£ 5.27M
Issuance Of Debt
-£ 36.01M£ -190.00K£ -211.00K--
Repayment Of Debt
£ -190.00K£ -174.00K£ -190.00K£ -211.00K£ -402.00K-
Free Cash Flow
£ -45.90M£ -39.40M£ -45.90M£ 6.81M£ -11.29M£ 1.72M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Silence Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis